PathAI and MedStar Health Partner to Deploy AISight Dx Digital Pathology Platform

PathAI and MedStar Health have entered into a multi-year strategic partnership to implement the AISight Dx digital pathology platform. This collaboration aims to modernize pathology workflows across MedStar Health laboratories in Maryland and Washington, D.C. The rollout includes advanced artificial intelligence applications designed to improve efficiency and diagnostic consistency for a network of over 40 pathologists. AISight Dx serves as a cloud-native image management system that supports laboratory workflows and research initiatives. It provides enterprise-scale slide management and seamless integration with AI algorithms to speed up clinical operations. MedStar Health will also utilize ArtifactDetect and TumorDetect to transform how pathologists review cases and manage quality control.

Advancing Diagnostic Precision

This enterprise-wide deployment follows MedStar’s successful participation in PathAI’s Early Access Program. Previously, the health system conducted an independent validation of the AIM-HER2 Breast algorithm. These foundational steps proved the clinical value of digital tools before moving to full-scale adoption across the hospital system. Dr. Moira Larsen, Physician Executive Director at MedStar Health, noted that digital pathology is a critical enabler for scaling high-quality care. The technology allows the health system to manage a growing outreach business while remaining connected across various regional locations. This modernization ensures that innovative diagnostics reach patients in everyday practice more effectively.

A Foundation for Future Research

The agreement also positions MedStar Health as a key member of the Precision Pathology Network. This global consortium focuses on generating real-world multimodal data and supporting clinical trials through biopharma partnerships. Such collaboration helps future-proof the pathology department while driving medical innovation and new diagnostic development.